Seeking Alpha

After rising nearly 25% yesterday on big volume, shares of Cell Therapeutics (CTIC -11%) give...

After rising nearly 25% yesterday on big volume, shares of Cell Therapeutics (CTIC -11%) give back a big chunk today. The stock has been volatile over the past few sessions, largely trading in tandem with big moves in competitor Peregrine Pharmaceuticals (PPHM -11%), who announced favorable news on Mondary of its review of data on its experimental cancer drug bavituximab, saying it wasn't comprimised.
Comments (1)
  • grateful908
    , contributor
    Comments (78) | Send Message
     
    RUN FROM CTIC.... IF YOU BUY, YOU WILL LOSE MONEY!!!!! I GUARANTEE YOU THAT.
    10 Jan 2013, 12:47 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs